Document ID: chunk:federal_register_of_legislation:F2016L00262:reg:7
Version: federal_register_of_legislation:F2016L00262
Segment Type: reg
Provision Reference: reg 7
Character Range: 1653–3434

7               Kind of injury, disease or death to which this Statement of Principles relates
(1)          This Statement of Principles is about systemic lupus erythematosus and death from systemic lupus erythematosus.
      Meaning of systemic lupus erythematosus
(2)          For the purposes of this Statement of Principles, systemic lupus erythematosus means:
(a)           a chronic inflammatory autoimmune disease characterised by the presence of antibodies directed against cell nuclei and variable clinical manifestations in multiple systems and organs.  Common features include polyarthritis and arthralgia, photosensitivity, rash, serositis, and renal, haematological and neurological disorders; and
(b)                         excludes discoid lupus erythematosus and mixed connective tissue disease.
(3)          While systemic lupus erythematosus attracts ICD‑10‑AM code M32, L93.1 or L93.2, in applying this Statement of Principles the meaning of systemic lupus erythematosus is that given in subsection (2).
(4)          For subsection (3), a reference to an ICD‑10‑AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD‑10‑AM), Ninth Edition, effective date of 1 July 2015, copyrighted by the Independent Hospital Pricing Authority, ISBN 978‑1‑76007‑020‑5.
Death from systemic lupus erythematosus
(5)          For the purposes of this Statement of Principles, systemic lupus erythematosus, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's systemic lupus erythematosus.
Note: terminal event is defined in the Schedule 1 – Dictionary.